These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32747931)

  • 1. Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.
    Cheknis A; Devaris D; Chesnel L; Dale SE; Nary J; Sambol SP; Citron DM; Goering RV; Johnson S
    J Antimicrob Chemother; 2020 Nov; 75(11):3120-3125. PubMed ID: 32747931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.
    Lew T; Putsathit P; Sohn KM; Wu Y; Ouchi K; Ishii Y; Tateda K; Riley TV; Collins DA
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393487
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015.
    Cheknis A; Johnson S; Chesnel L; Petrella L; Sambol S; Dale SE; Nary J; Sears P; Citron DM; Goldstein EJC; Gerding DN
    Anaerobe; 2018 Oct; 53():38-42. PubMed ID: 29886050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
    Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
    Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021.
    Abdrabou AMM; Bischoff M; Mellmann A; von Müller L; Margardt L; Gärtner BC; Berger FK;
    Anaerobe; 2022 Oct; 77():102548. PubMed ID: 35307546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014-2019.
    Abdrabou AMM; Ul Habib Bajwa Z; Halfmann A; Mellmann A; Nimmesgern A; Margardt L; Bischoff M; von Müller L; Gärtner B; Berger FK
    Int J Med Microbiol; 2021 May; 311(4):151507. PubMed ID: 33915347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strains.
    Kociolek LK; Perdue ER; Fawley WN; Wilcox MH; Gerding DN; Johnson S
    Anaerobe; 2018 Dec; 54():1-7. PubMed ID: 30009944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridioides (Clostridium) difficile in adults with diarrhoea in Vietnam.
    Khun PA; Phi LD; Bui HTT; Collins DA; Riley TV
    Anaerobe; 2023 Jun; 81():102741. PubMed ID: 37244476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of strain typing results for Clostridium difficile isolates from North America.
    Tenover FC; Akerlund T; Gerding DN; Goering RV; Boström T; Jonsson AM; Wong E; Wortman AT; Persing DH
    J Clin Microbiol; 2011 May; 49(5):1831-7. PubMed ID: 21389155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of
    Wieczorkiewicz JT; Skinner AM; Cheknis A; Petrella LA; Stevens VW; Wright LM; Gerding DN; Johnson S
    Antimicrob Agents Chemother; 2024 Aug; 68(8):e0069824. PubMed ID: 38953622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridioides (Clostridium) difficile in children with diarrhoea in Vietnam.
    Khun PA; Phi LD; Pham PT; Thu Nguyen HT; Huyen Vu QT; Collins DA; Riley TV
    Anaerobe; 2022 Apr; 74():102550. PubMed ID: 35331913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
    Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG
    J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019.
    Du T; Choi KB; Silva A; Golding GR; Pelude L; Hizon R; Al-Rawahi GN; Brooks J; Chow B; Collet JC; Comeau JL; Davis I; Evans GA; Frenette C; Han G; Johnstone J; Kibsey P; Katz KC; Langley JM; Lee BE; Longtin Y; Mertz D; Minion J; Science M; Srigley JA; Stagg P; Suh KN; Thampi N; Wong A; Hota SS
    Emerg Infect Dis; 2022 Jun; 28(6):1128-1136. PubMed ID: 35470794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of endemic Clostridioides difficile infection in Japan.
    Senoh M; Kato H
    Anaerobe; 2022 Apr; 74():102510. PubMed ID: 34990814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of surotomycin against contemporary clinical isolates of toxigenic Clostridium difficile strains obtained in Spain.
    Reigadas E; Alcalá L; Marín M; Pelaéz T; Martin A; Iglesias C; Bouza E
    J Antimicrob Chemother; 2015 Aug; 70(8):2311-5. PubMed ID: 25876881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.
    Krutova M; Capek V; Nycova E; Vojackova S; Balejova M; Geigerova L; Tejkalova R; Havlinova L; Vagnerova I; Cermak P; Ryskova L; Jezek P; Zamazalova D; Vesela D; Kucharova A; Nemcova D; Curdova M; Nyc O; Drevinek P
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):98. PubMed ID: 32605598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
    Freeman J; Vernon J; Pilling S; Morris K; Nicolson S; Shearman S; Clark E; Palacios-Fabrega JA; Wilcox M;
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):169-177. PubMed ID: 31811507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018.
    Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017.
    Tickler IA; Obradovich AE; Goering RV; Fang FC; Tenover FC;
    Anaerobe; 2019 Dec; 60():102050. PubMed ID: 31173889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
    Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
    Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.